Hylo Knee Injection contains Sodium Hyaluronate 15mg as its active ingredient, a viscoelastic substance that mimics the natural synovial fluid found in healthy joints. It is primarily indicated for the treatment of osteoarthritis-related knee pain and joint dysfunction. By restoring the viscoelasticity and lubricating properties of synovial fluid, Hylo Knee Injection helps to reduce friction between cartilage surfaces, thereby alleviating pain and improving joint mobility. The injection is administered intra-articularly, directly into the affected knee joint, providing targeted relief. Sodium Hyaluronate also exhibits anti-inflammatory effects, contributing to the reduction of joint swelling and stiffness. This treatment is particularly beneficial for patients who have not achieved adequate symptom control with oral analgesics or nonsteroidal anti-inflammatory drugs (NSAIDs), or for those who seek to delay surgical intervention such as knee replacement. Hylo Knee Injection is generally well tolerated, with adverse effects typically limited to mild local reactions such as transient pain or swelling at the injection site. It is contraindicated in patients with known hypersensitivity to hyaluronic acid preparations or any component of the formulation. Proper aseptic technique should be employed during administration to minimize the risk of joint infection.